Abeona Therapeutics (ABEO) Return on Invested Capital (2026)

Abeona Therapeutics (ABEO) recorded quarterly Return on Invested Capital of 0.0% in Q1 2026.

Abeona Therapeutics (ABEO) Return on Invested Capital (2026) Analysis & Trends

Abeona Therapeutics' Return on Invested Capital history runs 1 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital was 0.0% for Q1 2026 at Abeona Therapeutics.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.01%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -0.01%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -0.01%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Abeona Therapeutics 325.29 Mn 157.02 Mn 6.02 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%